Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 9, 1977 - Issue 2
Submit an article Journal homepage
5
Views
4
CrossRef citations to date
0
Altmetric
Main Article

Uptake of 5(125I) iodo-2-Deoxyuridine (IDU) in Plasma and Cerebrospinal Fluid in a Case of Herpes Encephalitis with a Comparative Study on the Uptake in Plasma, Cerebrospinal Fluid and Brain Tissue in Dogs

Otto Paulsen Department of Infectious Diseases, University Hospital, Lund, Sweden
Pages 85-89 | Published online: 02 Jan 2015

References

  • . Allen, L. B. & Sidwell, R. W.: Target-organ treatment of neurotropic virus diseases: Efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine. Antimicrob Agents Chemother 2: 229, 1972.
  • . Bellanti, J. A., Catalano, L. W. & Chambers, R. W.: Herpes simplex encephalitis: Virologic and serologic study of a patient treated with an interferon inducer. J Pediatr 78: 136, 1971.
  • . Bellanti, J. A., Guin, G. H., Grassi, R. M. & Olson, L. C.: Herpes simplex encephalitis: Brain biopsy and treatment with 5-iodo-2-deoxyuridine. J Pediatr 72: 266, 1968.
  • . Breeden, C. J., Hall, T. C. & Tyler, H. R.: Herpes simplex encephalitis treated with systemic 5-iodo-2-deoxyuridine. Ann Intern Med 65: 1050, 1966.
  • . Cheng, Yung-Chi.: A rational approach to the development of antiviral chemotherapy: Alternative substrates of herpes simplex virus type I (HSV-I) and type II (HSV-II) thymidine kinase (TK). NY Acad Sci, Symposium on antiviral substances, 1976.
  • . Clarkson, D. R., Oppelt, W. W. & Byvoet, P.: The fate of 5-iodo-2-deoxyuridine (IUdR) in plasma and cerebrospinal fluid of dogs. J Pharmacol Exp Ther 137: 581, 1967.
  • . Evans, A. D., Gray, O. P., Miller, M. H., Jones Verrier, E. R., Weeks, R. D. & Wells, C. E. C.: Herpes simplex encephalitis treated with intravenous idoxuridine. Br Med J 2: 407, 1967.
  • . Farris, W. A. & Blaw, M. E.: Cytarabine treatment of herpes simplex encephalitis. Arch Neurol 27: 99, 1972.
  • . Griffith, J. F., Fitzwilliam, J. F., Casagrande, S. & Butler, S. R.: Experimental herpes simplex virus encephalitis: Comparative effects of treatment with cytosine arabinoside and adenine arabinoside. J Infect Dis 132: 506, 1975.
  • . Hryniuk, W., Foerster, J., Shojania, M. & Chow, A.: Cytarabine for herpesvirus infections. JAMA 219: 715, 1972.
  • . Kern, E. R., Overall, J. C., Jr & Glasgow, L. A.: Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J Infect Dis 128: 290, 1973.
  • . Lauter, C. B., Bailey, E. J. & Lerner, A. M.: Absence of idoxuridine and persistence of herpes simplex virus in brains of patients being treated for encephalitis (38966). Proc Soc Exp Biol Med 150: 23, 1975.
  • . Lerner, A. M. & Bailey, E. J.: Concentrations of idoxuridine in serum, urine and cerebrospinal fluid of patients with suspected diagnoses of herpesvirus hominis encephalitis. J Clin Invest 51: 45, 1972.
  • . Lopez, C. & Giner-Sorolla, A.: Arabinosyl-N6-hydroxyadenine: A new potent antivirus drug. NY Acad Sci, Symposium on antiviral substances, 1976.
  • . Nolan, D. C., Carruthers, M. M. & Lerner, A. M.: Herpesvirus hominis encephalitis in Michigan. N Engl J Med 282: 10, 1970.
  • . Olson, L. C., Buescher, E. L., Artenstein, M. S. & Parkman, P. D.: Herpesvirus infections of the human central nervous system. N Engl J Med 277: 1271, 1967.
  • . O'Neill, F. J., Goldberg, R. J. & Rapp, F.: Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside. J Gen Virol 14: 189, 1972.
  • . Panitch, H. S. & Baringer, J. R.: Experimental herpes simplex encephalitis. Arch Neurol 28: 371, 1973.
  • . Person, D. A., Sheridan, P. J. & Herrmann, E. C.: Sensitivity of types 1 and 2 herpes simplex virus to 5-iodo-2-deoxyuridine and 9-β-D-arabinofuranosyladenine. Infect Immun 2: 815, 1970.
  • . Sarubbi, F. A., Jr, Sparling, P. F., Glezen, W. P. & Hill, C.: Herpesvirus hominis encephalitis. Arch Neurol 29: 268, 1973.
  • . Sloan, B. J., Miller, F. A. & McLean, I. W., Jr: Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-β-D-arabinofuranosyladenine. Antimicrob Agents Chemother 3: 74, 1973.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.